Валюты / ALC
ALC: Alcon Inc
87.49
USD
0.64
(0.73%)
Курс ALC за сегодня изменился на -0.73%. При этом минимальная цена на торгах достигала 87.38, а максимальная — 88.23.
Следите за динамикой Alcon Inc. Котировки в реальном времени помогут быстро реагировать на изменения рынка. Переключаясь между различными таймфреймами, можно отслеживать тенденции и динамику курса по минутам, часам, дням, неделям и месяцам. Используйте эту информацию для прогнозирования изменений на рынке и принятия взвешенных торговых решений.
- M5
- M15
- H1
- H4
- D1
- W1
- MN
Новости ALC
- Investing Stifel reiterates Buy rating on Alcon stock, maintains $100 price target
- Investing RxSight stock rating downgraded to Neutral by BTIG amid sales challenges
- Investing Alcon’s vitreoretinal-cataract system receives Health Canada approval
- Investing Alcon to acquire LumiThera and its dry AMD light therapy device
- Investing DP World subsidiary to acquire 51% stake in NovaAlgoma cement assets
- Investing Stifel reiterates Buy rating on Alcon stock amid IOL market dynamics
- Investing UBS downgrades Galderma to “neutral” on valuation concerns, softer aesthetics
- Investing Alcon Canada Earns Global Recognition as a Top Employer
- Investing # Alcon’s new eye lens reduces light scatter for cataract patients
- Seeking Alpha Impax Global Social Leaders Fund Q1 2025 Commentary (Mutual Fund:IGSLX)
- Investing UBS identifies stock winners amid structural growth tailwinds
- Seeking Alpha Alcon’s Tryptyr Adds Growth, But Valuation Keeps Shares On 'Hold' (NYSE:ALC)
- Investing Citi more constructive on EU MedTech: Upgrades Demant; Alcon top pick
- Seeking Alpha Thornburg Better World International Fund Q1 2025 Commentary
- Investing BofA Securities lowers Alcon stock price target after Q1 results
- Investing Analysts assess the potential impact of Trump’s surprise 50% steel tariffs
- Investing Citi maintains Buy on Alcon, price target CHF99 after FDA nod
- Seeking Alpha Madison Large Cap Fund Q1 2025 Investment Strategy Letter
- Benzinga Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019 - Alcon (NYSE:ALC)
- Investing BTIG maintains Alcon $99 target, upbeat on TRYPTYR launch
- Investing FDA approves Alcon’s TRYPTYR for Dry Eye Disease treatment
- Investing BTIG maintains Alcon stock Buy rating, $99 target
- Investing Lifecore stock gains on Outperform rating by William Blair
- Investing Stifel maintains Alcon stock Buy rating, $100 target amid new drug launch
Дневной диапазон
87.38
88.23
Годовой диапазон
80.48
101.10
- Предыдущее закрытие
- 88.71
- Open
- 88.13
- Bid
- 87.49
- Ask
- 87.79
- Low
- 87.38
- High
- 88.23
- Объем
- 2.693 K
- Дневное изменение
- -0.73%
- Месячное изменение
- -0.31%
- 6-месячное изменение
- -3.50%
- Годовое изменение
- -6.35%
14 июля, понедельник
15:30
USD
- Акт.
- Прог.
- Пред.
- 4.255%
15:30
USD
- Акт.
- Прог.
- Пред.
- 4.145%